{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:12:29Z","timestamp":1768266749131,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ajo.2023.11.012","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T04:22:41Z","timestamp":1700194961000},"page":"141-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Effectiveness of Propranolol in Preventing Severe Retinopathy of Prematurity: A Comprehensive Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"259","author":[{"given":"Muhammad Ashir","family":"Shafique","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Haseeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Musab Nafees","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bushra","family":"Asghar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eymaan Riaz","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moosa Abdur","family":"Raqib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Muhammad Sinaan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3067-3543","authenticated-orcid":false,"given":"Muhammad Saqlain","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2023.11.012_bib0001","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000312821","article-title":"Infection, oxygen, and immaturity: interacting risk factors for retinopathy of prematurity","volume":"99","author":"Chen","year":"2011","journal-title":"Neonatology"},{"issue":"suppl 1","key":"10.1016\/j.ajo.2023.11.012_bib0002","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.ajo.2023.11.012_bib0003","doi-asserted-by":"crossref","first-page":"F179","DOI":"10.1136\/archdischild-2014-306207","article-title":"Impact of retinopathy of prematurity on ocular structures and visual functions","volume":"100","author":"Fielder","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1-1","key":"10.1016\/j.ajo.2023.11.012_bib0004","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/pr.2015.181","article-title":"Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity","volume":"79","author":"Hellgren","year":"2016","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1016\/j.ajo.2023.11.012_bib0005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clp.2019.05.008","article-title":"Oxygen saturation and retinopathy of prematurity","volume":"46","author":"Higgins","year":"2019","journal-title":"Clin Perinatol"},{"issue":"5","key":"10.1016\/j.ajo.2023.11.012_bib0006","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","article-title":"Retinopathy of prematurity: a review of risk factors and their clinical significance","volume":"63","author":"Kim","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"9902","key":"10.1016\/j.ajo.2023.11.012_bib0007","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ajo.2023.11.012_bib0008","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","article-title":"Vascular endothelial growth factor A in intraocular vascular disease","volume":"120","author":"Miller","year":"2013","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2023.11.012_bib0009","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1167\/iovs.10-5536","article-title":"Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade","volume":"52","author":"Ristori","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2023.11.012_bib0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00210-012-0828-x","article-title":"Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants","volume":"386","author":"Dal Monte","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"10.1016\/j.ajo.2023.11.012_bib0011","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/med.21336","article-title":"Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the \u03b2-adrenergic system","volume":"35","author":"Filippi","year":"2015","journal-title":"Med Res Rev"},{"issue":"3","key":"10.1016\/j.ajo.2023.11.012_bib0012","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/med.21874","article-title":"\u03b23-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: suggestive clues from embryo","volume":"42","author":"Filippi","year":"2022","journal-title":"Med Res Rev"},{"key":"10.1016\/j.ajo.2023.11.012_bib0013","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","article-title":"Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective","volume":"62","author":"Chan-Ling","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2023.11.012_bib0014","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clp.2013.02.005","article-title":"Current and future trends in treatment of severe retinopathy of prematurity","volume":"40","author":"Wallace","year":"2013","journal-title":"Clin Perinatol"},{"issue":"4-6","key":"10.1016\/j.ajo.2023.11.012_bib0015","first-page":"127","article-title":"[Complications of intravitreal injections\u2014own experience]","volume":"113","author":"Jamrozy-Witkowska","year":"2011","journal-title":"Klin Oczna"},{"issue":"2","key":"10.1016\/j.ajo.2023.11.012_bib0016","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaapos.2017.12.005","article-title":"Ocular complications following treatment in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study","volume":"22","author":"Morrison","year":"2018","journal-title":"J AAPOS"},{"issue":"24","key":"10.1016\/j.ajo.2023.11.012_bib0017","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2023.11.012_bib0018","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2431-10-83","article-title":"Study protocol: Safety and Efficacy of Propranolol in Newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491","volume":"10","author":"Filippi","year":"2010","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.ajo.2023.11.012_bib0019","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.preteyeres.2014.06.001","article-title":"The \u03b2-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases","volume":"42","author":"Casini","year":"2014","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.ajo.2023.11.012_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054698","article-title":"\u03b2-Adrenoreceptors as therapeutic targets for ocular tumors and other eye diseases\u2014historical aspects and nowadays understanding","volume":"24","author":"B\u00f6hm","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ajo.2023.11.012_bib0021","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MOP.0000000000000650","article-title":"Infantile hemangiomas: what have we learned from propranolol?","volume":"30","author":"Hagen","year":"2018","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"10.1016\/j.ajo.2023.11.012_bib0022","first-page":"48","article-title":"Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"10.1016\/j.ajo.2023.11.012_bib0023","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/jiaps.jiaps_3_21","article-title":"Oral atenolol versus propranolol in the treatment of infantile hemangioma: a systematic review and meta-analysis","volume":"27","author":"Pattanshetti","year":"2022","journal-title":"J Indian Assoc Pediatr Surg"},{"issue":"1","key":"10.1016\/j.ajo.2023.11.012_bib0024","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000381659","article-title":"Oral propranolol: a new treatment for infants with retinopathy of prematurity?","volume":"108","author":"B\u00fchrer","year":"2015","journal-title":"Neonatology"},{"key":"10.1016\/j.ajo.2023.11.012_bib0025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fped.2019.00180","article-title":"Propranolol 0.2% eye micro-drops for retinopathy of prematurity: a prospective phase IIB study","volume":"7","author":"Filippi","year":"2019","journal-title":"Front Pediatr"},{"issue":"9","key":"10.1016\/j.ajo.2023.11.012_bib0026","doi-asserted-by":"crossref","DOI":"10.1111\/apa.16850","article-title":"Treating infants with 0.2% propranolol eye micro-drops drastically reduced the progression of retinopathy of prematurity","volume":"112","author":"Scaramuzzo","year":"2023","journal-title":"Acta Paediatr"},{"issue":"6","key":"10.1016\/j.ajo.2023.11.012_bib0027","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.jpeds.2013.07.049","article-title":"Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives","volume":"163","author":"Filippi","year":"2013","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.ajo.2023.11.012_bib0028","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/archdischild-2013-303951","article-title":"Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study","volume":"98","author":"Makhoul","year":"2013","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.ajo.2023.11.012_bib0029","doi-asserted-by":"crossref","first-page":"F389","DOI":"10.1136\/archdischild-2016-311548","article-title":"Prophylactic propranolol for prevention of ROP and visual outcome at 1 year (PreROP trial)","volume":"102","author":"Sanghvi","year":"2017","journal-title":"Arch Dis Child Fetal Neonat Ed"},{"issue":"1","key":"10.1016\/j.ajo.2023.11.012_bib0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/02713683.2016.1158272","article-title":"The efficacy of propranolol in retinopathy of prematurity and its correlation with the platelet mass index","volume":"42","author":"Korkmaz","year":"2017","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2023.11.012_bib0031","first-page":"266","article-title":"The efficacy and safety of oral propranolol in the treatment of retinopathy of prematurity","author":"Sun","year":"2018","journal-title":"Chinese J Neonatol"},{"issue":"1","key":"10.1016\/j.ajo.2023.11.012_bib0032","article-title":"Efficacy of oral propranolol in prevention of severe retinopathy of prematurity: a randomized clinical trial study","volume":"14","author":"Mohammadi","year":"2023","journal-title":"Iran J Neonatol"},{"issue":"1","key":"10.1016\/j.ajo.2023.11.012_bib0033","doi-asserted-by":"crossref","DOI":"10.34172\/cjmb.2022.10","article-title":"Efficacy of oral propranolol on the treatment of retinopathy of prematurity","volume":"9","author":"Hosseini","year":"2022","journal-title":"Crescent J Med Biol Sci"},{"issue":"9","key":"10.1016\/j.ajo.2023.11.012_bib0034","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s10792-018-1018-8","article-title":"The efficacy of propranolol in very preterm infants at the risk of retinopathy of prematurity: which newborn and when?","volume":"39","author":"Ozturk","year":"2019","journal-title":"Int Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2023.11.012_bib0035","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited","volume":"123","year":"2005","journal-title":"Arch Ophthalmol (Chicago, Ill: 1960)"},{"issue":"12","key":"10.1016\/j.ajo.2023.11.012_bib0036","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41372-019-0503-x","article-title":"Oral propranolol in prevention of severe retinopathy of prematurity: a systematic review and meta-analysis","volume":"39","author":"Stritzke","year":"2019","journal-title":"J Perinatol"},{"key":"10.1016\/j.ajo.2023.11.012_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.631673","article-title":"Clinical efficacy and safety of propranolol in the prevention and treatment of retinopathy of prematurity: a meta-analysis of randomized controlled trials","volume":"9","author":"Kong","year":"2021","journal-title":"Front Pediatr"},{"issue":"10","key":"10.1016\/j.ajo.2023.11.012_bib0038","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","article-title":"Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity","volume":"114","author":"Pierce","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2023.11.012_bib0039","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00417-008-0865-9","article-title":"The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity","volume":"246","author":"Kwinta","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2023.11.012_bib0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/JEP.S146211","article-title":"Propranolol for the treatment of vascular sarcomas","volume":"10","author":"Wagner","year":"2018","journal-title":"J Exp Pharmacol"},{"issue":"5","key":"10.1016\/j.ajo.2023.11.012_bib0041","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1167\/iovs.09-4779","article-title":"Systemic propranolol reduces b-wave amplitude in the ERG and increases IGF-1 receptor phosphorylation in rat retina","volume":"51","author":"Jiang","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2023.11.012_bib0042","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/MOP.0b013e32833bb764","article-title":"Update on vascular tumors of infancy","volume":"22","author":"Sidbury","year":"2010","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"10.1016\/j.ajo.2023.11.012_bib0043","doi-asserted-by":"crossref","first-page":"33","DOI":"10.24911\/SJP.106-1536134988","article-title":"Use of propranolol in children with primary nocturnal enuresis","volume":"18","author":"\u00c7aksen","year":"2018","journal-title":"Sudan J Paediatr"},{"issue":"4","key":"10.1016\/j.ajo.2023.11.012_bib0044","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/157488611798280889","article-title":"Propranolol safety profile in children","volume":"6","author":"El-Shabrawi","year":"2011","journal-title":"Current Drug Saf"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423004749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423004749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:55:07Z","timestamp":1757598907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423004749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":44,"alternative-id":["S0002939423004749"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.11.012","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Propranolol in Preventing Severe Retinopathy of Prematurity: A Comprehensive Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}